WO2005077942A1 - Process for preparing substituted benzopyran compounds - Google Patents

Process for preparing substituted benzopyran compounds Download PDF

Info

Publication number
WO2005077942A1
WO2005077942A1 PCT/KR2005/000365 KR2005000365W WO2005077942A1 WO 2005077942 A1 WO2005077942 A1 WO 2005077942A1 KR 2005000365 W KR2005000365 W KR 2005000365W WO 2005077942 A1 WO2005077942 A1 WO 2005077942A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
compound
following formula
solvates
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2005/000365
Other languages
English (en)
French (fr)
Inventor
Nam Kyu Lee
Ju Young Lee
Jae-Sun Kim
Jae Yoon Jung
Key An Um
Yong Ho Oh
Ho Chul Shin
Woo Jae Jang
Guang-Jin Im
Tae Kon Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Chemicals Co Ltd
Original Assignee
SK Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Chemicals Co Ltd filed Critical SK Chemicals Co Ltd
Priority to JP2006553050A priority Critical patent/JP4512100B2/ja
Priority to CN2005800047261A priority patent/CN1918150B/zh
Priority to EP05726439A priority patent/EP1713796A4/en
Publication of WO2005077942A1 publication Critical patent/WO2005077942A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • the present invention relates to a novel method of preparing substituted benzopyran compounds of the following formula 1, their corresponding novel intermediates and a method of their preparation thereof.
  • a benzopyran compound is a leukotriene-receptor antagonist already disclosed in EP 0173516 and others, which is also known as a therapeutic agent for treating diseases induced by leukotriene and 5- ⁇ -reductase.
  • JP Hei 3- 95144 discloses a method of preparing 3-amino-2-hydroxyacetophenone from the phenol compound of the following formula (A) via a four step process.
  • this method is not considered efficient due to its rather long process and also it lacks industrial applicability due to the risk of explosion during a hydrogenation reaction using Pd/C in the reduction step (a) for introducing an amino group.
  • X indicates a halogen atom.
  • This invention relates to a method of synthesizing a few novel benzopyran compounds disclosed in EP 0173516.
  • the method of the present invention is industrially more applicable since it provides an added safety and efficiency with a fewer number of steps in process as compared to the conventional methods.
  • the method of this invention follows the convergent pathway, a more efficient process than the conventional linear process.
  • the method of the present invention does not employ a risky process such as hydrogenation reaction and the intermediate materials produced during the reaction are so stable that their separation and purification are quite easy.
  • This invention relates to a method of preparing substituted benzopyran compounds having the chemical structure of the following formula 1, a novel intermediate compound used for the process thereof, and a method of preparing the intermediate compound.
  • R 1 is selected from the group consisting of a Q-2o alkyl group, a C2-20 alkenyl group, a C2-20 alkynyl group, a phenyl group, a naphthalenyl group and an indanyl group, wherein the groups can be independently substituted by 1 or 2 substituents selected from a C ⁇ -2 o alkyl group, a C 2-2 o alkenyl group and a C 2-2 o alkynyl group, wherein up to 5 carbon atoms of the substitution groups can be selectively substituted by O, S, N, a halogen atom, a benzene ring, a thiophene ring, a naphthalene ring, a C4-7 carbocyclic ring, a carbonyl group, a carbonyloxy group, a hydroxyl group, a carboxy group, an azido group or a nitro group; R 2 and R 4 are independently
  • R 1 is a phenyl group or a substituted phenyl group, wherein the above substituted phenyl group can be substituted with 1 or 2 substituents selected from a C1-20 alkyl group, a C2-20 alkenyl group and a C2-20 alkynyl group, wherein up to 5 carbon atoms of the substitution groups can be selectively substituted by O, S, N, a halogen atom, a benzene ring, a thiophene ring, a naphthalene ring, a C -7 carbocyclic ring, a carbonyl group, a carbonyloxy group, a hydroxyl group, a carboxy group, an azido group or a nitro group.
  • R 1 is a phenyl group substituted at p-position with a substituent from those exemplified above, and more preferably
  • R 2 and R 4 are independently H, a Ci-6 alkyl group, a C2-6 alkenyl group, a Ci-6 alkyl group substituted with from 1 to 3 aryl groups, or a Ci-6 alkoxycarbonyl group. More preferably, R 2 and R 4 are independently H.
  • R 3 is H. In preparing the substituted benzopyran compounds of the above formula 1,
  • A is a single bond; or a methylene, ethylene, trimethylene, tetramethylene, vinylene, propenylene, butenylene, butadienylene or ethynylene group either substituted or unsubstituted with from 1 to 3 substituents selected from a C ⁇ -10 alkyl group and a phenyl group. More preferably, A is a single bond.
  • the substituted benzopyran compounds of the above formula 1 according to the present invention can be prepared by reacting a compound of the following formula 2 with a compound of the following formula 3 as shown in the following reaction scheme 1.
  • reaction Scheme 1 In the above reaction scheme 1, R 1 , R 2 , R 3 , R 4 , A, X and Y are the same as defined in the above formula 1.
  • the above preparation method according to the reaction scheme 1 is performed at reflux temperature using an organic solvent in the presence of a Pd or Cu catalyst, a ligand and a base.
  • the solvent used in the above reaction can be selected from those having high polarity such as ⁇ N'-dimethylformamide, N-methylpyrolidone, pyridine, 1,4- dioxane, C ⁇ -6 alkanol(methanol, ethanol, f-butanol) or a mixture thereof, and preferably N ⁇ N'-dimethylformamide.
  • the catalyst used in the above reaction is a Pd- or Cu-containing compound and is used in the range of about 0.1 to 100 mol% with reference to the amomnt of reactants.
  • the catalyst is selected from the group consisting of Cul, CuCl, and Q12O, and more preferably Cul.
  • the ligand in the above reaction is used in the range of about 0.5 to 3 equivalents with reference to the amount of the catalyst being used.
  • the ligand used is diamines or phosphines, preferably the one selected from the group consisting of N,N'-dimethylethylenediamine, trans-N,N'-l,2-cyclohexanediamine and trans-iV,N'- dimethyl-l,2-cyclohexanediamine, and more preferably JSf,N'- dimethylethylenediamine.
  • the base in the above reaction is used in the range of about 1 to 10 equivalents with reference to the substrate material.
  • the base can be selected from the group consisting of alkali metal alkoxide such as potassium .r-butoxide, potassium methoxide, and sodium methoxide; hydrides such as sodium hydride and potassium hydride; alkali metal carbonate such as potassium carbonate, cesium carbonate, and sodium carbonate; or an alkali metal phosphate such as potassium phosphate and sodium phosphate; and preferably an alkali metal phosphate.
  • alkali metal alkoxide such as potassium .r-butoxide, potassium methoxide, and sodium methoxide
  • hydrides such as sodium hydride and potassium hydride
  • alkali metal carbonate such as potassium carbonate, cesium carbonate, and sodium carbonate
  • an alkali metal phosphate such as potassium phosphate and sodium phosphate
  • an alkali metal phosphate such as potassium phosphate and sodium phosphate
  • the substituted benzopyran compounds of the following formula la, its salts or its solvates are synthesized by reacting a compound of the following formula 2a with a compound of the following formula 3a, its salts or its solvates (e.g., hydrates).
  • the reaction is performed while stirring at about 70 to about 100°C for more than a day using ,N'-dimethylformamide as a solvent in the presence of Cul as a catalyst, N,N'-dimethylethylenedia ine as a ligand, and potassium phosphate as a base.
  • the reactants i.e., the compound of the above formula 2 (especially the compound of the above formula 2a) and the compound of the above formula 3 (especially the compound of the above formula 3a), are novel intermediate compounds used in synthesizing the compound of the above formula 1. Therefore, the compounds of the above formulas 2 and 3 also belong to the scope of the present invention.
  • the compound of the above formula 2 being a novel intermediate compound according to the present invention, can be synthesized by hydrolysis of the compound of the following formula 4 as shown in the following reaction scheme 2.
  • reaction Scheme 2 (4) H ( 2)
  • R 1 , R 2 , A and Y are the same as defined in the above formula 1.
  • an amide group is introduced via hydrolysis using a base in the presence of water, an organic solvent or their mixture. The conditions for a base/ solvent used in the above hydrolysis will be apparent to those skilled in the art.
  • the reaction is performed using a single Ci-6 alkanol solvent such as methanol, ethanol, t-butanol or their mixture as a solvent while using alkali hydroxide such as sodium hydroxide or potassium hydroxide as a base.
  • alkali hydroxide such as sodium hydroxide or potassium hydroxide as a base.
  • the compounds of the following formula 2a, its salts or its solvates are synthesized by reacting the compound of the following formula 4a in the presence of NaOH/f-butanol.
  • the compound of the following formula 3 being a novel intermediate compound of the present invention, can be prepared by (a) synthesizing the compound of the following formula 7 by reacting the compound of the following formula 5 with the compound of the following formula 6, and then (b) performing cyclization reaction of thus obtained compound of the following formula 7, as shown in the following reaction scheme 3.
  • R 3 , R 4 and X are the same as defined in the above formula 1 and Z indicates an activated leaving group.
  • the activated leaving group (Z) of the above reaction scheme 3 are, for example, a halogen atom, an activated amide group represented by - N(R 6 )(OR 6 ) (wherein R 6 is a C ⁇ -6 alkyl group), R 7 0-, R 7 S- or R 7 S0 2 0- (wherein R 7 is a Ci-6 alkyl group, an arbitrarily substituted phenyl group or an arbitrarily substituted phenyl Ci-6 alkyl group), or
  • R 8 is a Ci-6 alkyl group, an arbitrarily substituted phenyl group or an arbitrarily substituted phenyl C 1-6 alkyl group, Y's are independently O or S).
  • the activated leaving group is R 7 0-, wherein R 7 is a Ci- ⁇ alkyl group, an arbitrarily substituted phenyl group or an arbitrarily substituted phenyl Ci-6 alkyl group, more preferably, R 7 is a Ci- ⁇ alkyl group, for example, a methyl group, an ethyl group, z— butyl group or t-butyl group, and most preferably R 7 is an ethyl group.
  • the step (a) of the synthesis according to the above reaction scheme 3 is performed in the presence of N,N'-dimethylformamide, an ether solvent such as tetrahydrofuran; an organic solvent such as toluene, benzene, hexane or a C ⁇ -6 alkanol (e.g., methanol, ethanol, t-butanol); and a base, wherein the base can be selected from the group consisting of alkali metal alkoxide such as potassium t- butoxide, potassium methoxide, and sodium methoxide; hydrides such as sodium hydride; and amides such as potassium amide and sodium amide.
  • an ether solvent such as tetrahydrofuran
  • an organic solvent such as toluene, benzene, hexane or a C ⁇ -6 alkanol (e.g., methanol, ethanol, t-butanol)
  • a base wherein the base
  • the cyclization in step (b) of the synthesis according to the above reaction scheme 3 is performed in the presence of an acid.
  • the cyclization can be performed in the presence of a sulfuric acid using a solvent such as Ci-e alkanol or acetic acid.
  • the cyclization can be performed in the presence of hydrochloric acid in the mixed solvent of Ci-6 alkanol/ tetrahydrofuran.
  • Alternative acid/ solvent conditions will be apparent to those skilled in the art.
  • the reaction can be performed in a suitable solvent such as water or Ci-6 alkanol, unsaturated carbocyclic hydrocarbon such as benzene or toluene, by using an acid such as hydrobromic acid, hydroiodic acid, perchloric acid or p-toluenesulfonic acid; and a Lewis acid such as aluminum trichloride or titanium, tetrachloride.
  • a suitable solvent such as water or Ci-6 alkanol, unsaturated carbocyclic hydrocarbon such as benzene or toluene
  • an acid such as hydrobromic acid, hydroiodic acid, perchloric acid or p-toluenesulfonic acid
  • a Lewis acid such as aluminum trichloride or titanium, tetrachloride.
  • the above reaction is performed in methanol solvent in the presence of sulfuric acid.
  • the compounds of the following formula 3a, its salts or its solvates are prepared by (a) synthesizing the compound of the following formula 7a, its salts and its solvates (e.g., hydrides) by reacting the compound of the following formula 5a with the compound of the following formula 6a, its salts and its solvates (e.g., hydrides) and then (b) performing the cyclization reaction of the compound of the following formula 7a, its salts and its solvates.
  • the compound of the above formula 7 (especially the compound of the above formula 7a) is a novel intermediate compound synthesized during the reaction. Therefore, the compound of the above formula 7 also belongs to the scope of the present invention.
  • the compound of the above formula 7 is indicated as di-keto type in this invention for convenience, but it can be also present in the form of keto-enol and cyclic hydroxy chromanone. Therefore, all of the tautomeric forms of the above formula 7 belong to the scope of this invention.
  • Example 1 Preparation of 4- (4-phenylbutoxy)benzamide To a mixture of 4-(4-phenylbutoxy)benzonitrile (1.9 g, 7.5 mmol) and t- butanol (37 mL) was added NaOH (2.1 g, 38 mmol) and refluxed for 4 hours. The mixture was cooled to room temperature and then added to a mixed solution of water and methanol (4 : 1, 100 mL). The resulting precipitate was filtered, washed with water and then dried under vacuum to give the target compound as a white solid (1.9 g, 94%).
  • the mixture was cooled to room temperature and then slowly added to cold IN HC1 (120 mL).
  • the resulting orange precipitate was filtered, washed with water and then dried under vacuum to obtain the target compound.
  • the target compound was dissolved in ethylacetate by applying heat, added with hexane and then placed at 0 °C for 2 hours.
  • the resulting product was filtered, washed with hexane and then dried under vacuum to give the purified product as a yellow solid(1.7 g, 83%).
  • Example 3 Preparation of 8-iodo-4-oxo-2-tetrazol-5-yl-lH-l-benzopyran
  • the purified product obtained in Example 2(1.5 g, 4.2 mmol) was mixed in methanol(20 mL) and stirred to produce a slurry.
  • the slurry was then added with a cone, sulfuric acid (265 ⁇ L, 5.0 mmol) and refluxed for 7 hours.
  • the mixture was cooled to room temperature and then maintained at 0 °C for an hour.
  • the resulting product was filtered, washed with cold methanol, water and cold methanol.
  • the resulting product was dried under vacuum to afford the target compound as a pale yellow solid(1.3 g, 93%).
  • Example 4 Preparation of 4-oxo-8-[4-(4-ph.enylbutoxy)benzoylamino]-2-tetrazol-5- yl-4H-l-benzopyran Under the nitrogen atmosphere, the purified product obtained in Example 1 (108 mg, 0.40 mmol), the purified product obtained in Example 3 (68 mg, 0.20 mmol), Cul (11.4 mg, 0.04 mmol), potassium phosphate (255 mg, 0.80 mmol) and N,N'- dimemylethylenediamine (13 ⁇ L, 0.08 mmol) were mixed together. The mixture was then added with anhydrous dimethylforrriamide (1 mL) and stirred at 100 °C for two days.
  • the reaction solution was cooled to room temperature and added with water(15 mL).
  • the resulting solution was acidified to pHl-2 by adding a saturated HC1 solution.
  • the precipitated solid was filtered and the resulting solid was suspended in methanol(lOmL) and then filtered to remove the remaining purified product obtained in Example 1.
  • the obtained solid was dissolved in methanol (7mL) by adding sodium acetate (32 mg, 0.40 mmol) and then filtered.
  • the filtrate was added with saturated HC1 solution.
  • the precipitated solid was filtered, washed with cold methanol and then dried under vacuum to obtain the target compound as a pale yellow solid(77 mg, 81%).
  • the present invention relates to a manufacturing process suitable for industrial application, which provides a much improved and more efficient method with secured safety as compared to the conventional methods.
  • the compounds represented in the above formulas 2, 3 and 7 are novel intermediate compounds produced in the course of synthesizing substituted benzopyran compounds of the formula 1, and they will also be very useful in industrial application due to their great stability.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PCT/KR2005/000365 2004-02-12 2005-02-07 Process for preparing substituted benzopyran compounds Ceased WO2005077942A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2006553050A JP4512100B2 (ja) 2004-02-12 2005-02-07 置換ベンゾピラン化合物の製造方法
CN2005800047261A CN1918150B (zh) 2004-02-12 2005-02-07 取代的苯并吡喃化合物的制备方法
EP05726439A EP1713796A4 (en) 2004-02-12 2005-02-07 PROCESS FOR THE PREPARATION OF SUBSTITUTED BENZOPYRANE COMPOUNDS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020040009280A KR100683274B1 (ko) 2004-02-12 2004-02-12 치환된 벤조피란 화합물의 제조방법
KR10-2004-0009280 2004-02-12

Publications (1)

Publication Number Publication Date
WO2005077942A1 true WO2005077942A1 (en) 2005-08-25

Family

ID=34858705

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2005/000365 Ceased WO2005077942A1 (en) 2004-02-12 2005-02-07 Process for preparing substituted benzopyran compounds

Country Status (5)

Country Link
EP (1) EP1713796A4 (enExample)
JP (1) JP4512100B2 (enExample)
KR (1) KR100683274B1 (enExample)
CN (1) CN1918150B (enExample)
WO (1) WO2005077942A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637575B2 (en) 2008-06-05 2014-01-28 Novotyr Therapeutics Ltd. Modulators of protein kinase signaling
US9770454B2 (en) 2013-07-14 2017-09-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
US10912745B2 (en) 2015-02-05 2021-02-09 Tyrnovo Ltd. Combinations of IRS/Stat3 dual modulators and anti-cancer agents for treating cancer

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US389339A (en) * 1888-09-11 Friction-clutch
US4158663A (en) * 1977-07-15 1979-06-19 Warner-Lambert Company Process for the production of 2-substituted chromones
US4238495A (en) * 1976-01-30 1980-12-09 Miles Laboratories, Inc. 1-(4-Cyano-phenoxy)-2-hydroxy-3-[2-(5-1H-tetrazolyl)-chromon-5-yloxy]-propane and salts thereof
JPS60246384A (ja) * 1984-05-21 1985-12-06 Hokuriku Seiyaku Co Ltd クロモン−8−カルポキサミド誘導体

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1296469A (enExample) 1970-02-05 1972-11-15
CA960223A (en) * 1970-02-05 1974-12-31 Mervyn E. Peel Tetrazolyl chromones
CA1261835A (en) * 1984-08-20 1989-09-26 Masaaki Toda (fused) benz(thio)amides
DE58905874D1 (de) * 1988-05-03 1993-11-18 Basf Ag Verfahren zur Herstellung von Carbonsäurechloriden.
JPH0395144A (ja) * 1989-08-04 1991-04-19 Ono Pharmaceut Co Ltd アミノフェノール誘導体の製造方法
JPH051008A (ja) * 1991-06-19 1993-01-08 Mitsubishi Kasei Corp 1,4−ジシアノブテン類の製造法
GB9224922D0 (en) 1992-11-27 1993-01-13 Smithkline Beecham Plc Process
US5597929A (en) 1994-06-23 1997-01-28 Sumitomo Chemical Co., Ltd. Production process of 2-(tetrazol-5-yl)-4-oxo-4H-benzopyran
CH691301A5 (de) * 1995-06-29 2001-06-29 Sumitomo Chemical Co Verfahren zur Herstellung von 2-Acetyl-6-(4-(4-phenylbutoxy)benzoyl)aminophenol.
AR004029A1 (es) * 1995-10-20 1998-09-30 Smithkline Beecham Plc Nuevas formulaciones farmaceuticas
JPH09323955A (ja) * 1996-06-03 1997-12-16 Kao Corp 安息香酸誘導体及びこれを含有する医薬
EP0912510B1 (en) * 1996-07-01 2003-05-07 E.I. Du Pont De Nemours And Company Nickel catalyzed addition of -nh- containing compounds to vinyl and aryl halides
GB9700331D0 (en) 1997-01-09 1997-02-26 Smithkline Beecham Plc Process
TR199902759T2 (xx) * 1997-05-09 2000-01-21 H. Lundbeck A/S Sertindole �retimi i�in bir y�ntem
CN1863752A (zh) * 2002-08-02 2006-11-15 罗迪亚药业公司 铜催化的芳基化

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US389339A (en) * 1888-09-11 Friction-clutch
US4238495A (en) * 1976-01-30 1980-12-09 Miles Laboratories, Inc. 1-(4-Cyano-phenoxy)-2-hydroxy-3-[2-(5-1H-tetrazolyl)-chromon-5-yloxy]-propane and salts thereof
US4158663A (en) * 1977-07-15 1979-06-19 Warner-Lambert Company Process for the production of 2-substituted chromones
JPS60246384A (ja) * 1984-05-21 1985-12-06 Hokuriku Seiyaku Co Ltd クロモン−8−カルポキサミド誘導体

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ELLIS ET AL: "Benzopyrones. 7. Synthesis and antiallergic activity of some 2-(5-tetrazolyl) chromones.", J.MED.CHEM., vol. 15, no. 8, 1972, pages 865 - 867, XP002370955 *
See also references of EP1713796A4 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637575B2 (en) 2008-06-05 2014-01-28 Novotyr Therapeutics Ltd. Modulators of protein kinase signaling
US9770454B2 (en) 2013-07-14 2017-09-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
US10188659B2 (en) 2013-07-14 2019-01-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
US10912745B2 (en) 2015-02-05 2021-02-09 Tyrnovo Ltd. Combinations of IRS/Stat3 dual modulators and anti-cancer agents for treating cancer
US12201592B2 (en) 2015-02-05 2025-01-21 Tyrnovo Ltd. Combinations of IRS/STAT3 dual modulators and anti-cancer agents for treating cancer

Also Published As

Publication number Publication date
CN1918150B (zh) 2010-05-05
CN1918150A (zh) 2007-02-21
JP2007522206A (ja) 2007-08-09
KR20050081042A (ko) 2005-08-18
KR100683274B1 (ko) 2007-02-15
EP1713796A1 (en) 2006-10-25
EP1713796A4 (en) 2009-11-25
JP4512100B2 (ja) 2010-07-28

Similar Documents

Publication Publication Date Title
JP5817079B2 (ja) 6−(7−((1−アミノシクロプロピル)メトキシ)−6−メトキシキノリン−4−イルオキシ)−n−メチル−1−ナフトアミド、またはそれの薬学的に許容される塩を調製するための方法
JP2003508387A (ja) 二環式アンドロゲンおよびプロゲステロン受容体モジュレーター化合物および方法
JP3763828B2 (ja) ベンゾピラン化合物の前駆体合成のための中間体の製造方法
KR20110083870A (ko) 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
WO2005070909A1 (en) An improved process for the preparation of gefitinib
EP1713796A1 (en) Process for preparing substituted benzopyran compounds
CN100410255C (zh) 肌苷及其制造方法
CN114230526B (zh) 一种4-3(h)喹唑啉酮及其衍生物的合成方法
KR100760015B1 (ko) 벤조피란 화합물 합성용 중간체
KR100716274B1 (ko) 치환된 벤조피란 화합물 합성용 화합물
KR100740325B1 (ko) 치환된 벤조피란 화합물 합성용 화합물
US6114549A (en) Process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
WO2006132424A1 (ja) 4(3h)-キナゾリノン誘導体の製造方法
JP4607917B2 (ja) 8−アミノ−4−オキソ−2−(テトラゾール−5−イル)−4h−1−ベンゾピランまたはその塩の製造方法、及びその製造用中間体
WO2022015181A1 (en) Method and intermediate compounds for the preparation of menaquinone mk-7
CN105712939B (zh) 一种合成瑞舒伐他汀钙关键中间体的方法
JP5432910B2 (ja) ドデカヒドロ−ナフト−フラニル−カルバミン酸エステル中間体調製のための高純度合成プロセス
JP2002338570A (ja) 3−アミノ−1,8−ナフチリジン−2(1h)−オン誘導体の製造法
KR20050036409A (ko) 카바졸온 유도체 제조 방법
JPH0782267A (ja) 1,4−ベンゾオキサジン誘導体
HK1231871A1 (en) A process for the preparation of compound and synthetic intermediates thereof
KR20080113160A (ko) 8-아미노-4-옥소-2-(테트라졸-5-일)-4h-1-벤조피란 및이를 통한 프란누카스트의 제조 방법
HK1167136B (en) A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and synthetic intermediates thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 200580004726.1

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2006553050

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 2005726439

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 4970/DELNP/2006

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 2005726439

Country of ref document: EP